hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06286176, orgStudyIdInfo id: LIUIRB-200311-NR1, briefTitle: Breastfeeding Promotion in Lebanon Through a Salutogenic Intervention, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-11-17, primaryCompletionDateStruct date: 2023-06-30, completionDateStruct date: 2023-06-30, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Nabiha Ramadan, class: OTHER, collaborators name: Universitat de Girona, descriptionModule briefSummary: The study is a randomized control trial to assess the effect of a salutogenic intervention on breastfeeding initiation and duration of exclusive breastfeeding in Lebanon. In this Salutogenic intervention, infant feeding helpers will provide subjects of the intervention group breastfeeding related information, and will support these subjects by counseling and guiding them to find general resistance resources. This aims to increase sense of coherence and its parameters: comprehensibility, manageability and meaningfulness, which are the base of salutogenesis., conditionsModule conditions: Breast Feeding, conditions: Exclusive Breastfeeding, conditions: Salutogenesis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 101, type: ACTUAL, armsInterventionsModule interventions name: Videos with breastfeeding education material and encouraging messages, interventions name: Whatsapp group, outcomesModule primaryOutcomes measure: breastfeeding initiation, primaryOutcomes measure: Duration of Exclusive breastfeeding, secondaryOutcomes measure: Mean change in Self- esteem in participants from baseline to 6 months postpartum, secondaryOutcomes measure: The Change in Sense of Coherence (SOC) scores from baseline to 6 months postpartum, eligibilityModule sex: FEMALE, minimumAge: 20 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: Lebanese International University, city: Beirut, zip: 146404, country: Lebanon, geoPoint lat: 33.88894, lon: 35.49442, hasResults: False
protocolSection identificationModule nctId: NCT06286163, orgStudyIdInfo id: PA4099, briefTitle: Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Imperial College London, class: OTHER, collaborators name: Merck Sharp & Dohme LLC, descriptionModule briefSummary: This study is being done in order to understand what causes people to have a chronic cough, which is defined as a cough lasting for more than 8 weeks. The research team wish to find out whether there is any inflammation in the lungs of patients with chronic cough. The research team will also determine whether a suspected chemical produced in the body, called adenosine triphosphate (ATP) can be responsible for causing the chronic cough. In order to be able to find out what is abnormal in those who have a chronic cough, The research team will need to compare their results with those that do not have a chronic cough.In this study, the research team will examine 10 participants who suffer from chronic cough and 8 individuals who do not have a chronic cough and are healthy., conditionsModule conditions: Chronic Cough, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 18, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Presence of ATP in airways of idiopathic chronic cough patients and the localisation of P2X2/3 receptors in the airways, primaryOutcomes measure: Cough sensitivity and laryngeal sensitivity to exogenous ATP, primaryOutcomes measure: Examine the effects of exogenous ATP on the inflammatory response in the upper and lower airways., eligibilityModule sex: ALL, minimumAge: 30 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Royal Brompton & Harefield NHS Trust,, status: RECRUITING, city: London, zip: SW3 6HP, country: United Kingdom, contacts name: Sally Meah, SRN, role: CONTACT, phone: 0207 3518051, email: Sally.Meah@imperial.ac.uk, contacts name: Pankaj K Bhavsar, role: CONTACT, phone: 02075947961, email: p.bhavsar@imperial.ac.uk, geoPoint lat: 51.50853, lon: -0.12574, locations facility: Royal Brompton Hospital, status: RECRUITING, city: London, zip: SW3 6HP, country: United Kingdom, contacts name: Kian Fan Chung, MD, role: CONTACT, phone: 44205947959, email: f.chung@imperial.ac.uk, contacts name: Sally Meah, SRN, role: CONTACT, phone: 02073518051, email: Sally.Meah@imperial.ac.uk, geoPoint lat: 51.50853, lon: -0.12574, hasResults: False
protocolSection identificationModule nctId: NCT06286150, orgStudyIdInfo id: EC-2023-087(QX)-03, briefTitle: Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-09-15, primaryCompletionDateStruct date: 2025-07-15, completionDateStruct date: 2027-07-15, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: The First Affiliated Hospital of Guangzhou Medical University, class: OTHER, descriptionModule briefSummary: Robotic surgical systems have become a promising surgical assistance system, with unique advantages such as 3D high-definition visual system, highly flexible wrist-jointed instruments, and automatic fitering of hand tremors. Robotic surgical systems is applied in various fields including urology, general surgery, cardiothoracic surgery, head and neck surgery, and gynecology. Currently, the Da Vinci surgical robot system is the most widely used robot system globally. However, the Da Vinci robot system for single-port laparoscopic surgery has not yet been launched in China. Therefore, the investigators conduct a prespective, single-center study to evaluate the efficacy and safety of single-port surgical robot system in thoracic surgery., conditionsModule conditions: Lung Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Surgical robot system, outcomesModule primaryOutcomes measure: Intraoperative conversion rate, primaryOutcomes measure: Surgical complications rate, secondaryOutcomes measure: Intraoperating bleeding volume, secondaryOutcomes measure: Surgical time, secondaryOutcomes measure: Length of hospital admissions, secondaryOutcomes measure: Postoperative wound pain score, secondaryOutcomes measure: Surgeon satisfaction, secondaryOutcomes measure: Adverse events, secondaryOutcomes measure: Rate of re-admission to hospital, secondaryOutcomes measure: Rate of reoperation, secondaryOutcomes measure: Postoperative mortality, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The First Affiliated Hospital of Guangzhou Medical University, status: RECRUITING, city: Guangzhou, state: Guangdong, zip: 510000, country: China, contacts name: Jianxing He, M.D., role: CONTACT, phone: +86-20-83337792, email: hejx@vip.163.com, geoPoint lat: 23.11667, lon: 113.25, hasResults: False
protocolSection identificationModule nctId: NCT06286137, orgStudyIdInfo id: NL82922.078.22, briefTitle: Duration of Music Interventions and Pain Tolerance (DOMINANT), acronym: DOMINANT, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-02, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Erasmus Medical Center, class: OTHER, descriptionModule briefSummary: This study will investigate the effect of different durations of music interventions (1, 5 and 20 minutes of music) on pain tolerance., conditionsModule conditions: Pain, Acute, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: The randomized controlled trial will have four study arms. Subjects will be assigned to one of the four arms: control without music and music groups with 1 minute, 5 minutes and 20 minutes. All subjects will receive electric stimuli in three phases. In each phase, subject will be exposed to three consecutive stimuli. First a detection threshold will be measured. Secondly a baseline test will be performed in order to assess basic levels of pain endurance. Hereafter, the intervention phase starts. Subjects in the music groups will listen to 1, 5 and 20 minutes of their own preferred music through headphones. Directly after, all subjects will again receive three electric stimuli., primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: Due to the nature of the study and the music intervention, it is not possible to blind participants and investigators. However, participants will not be informed of the study arm to which they are randomized in advance., enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Listening to music for 1 minute, interventions name: Listening to music for 5 minutes, interventions name: Listening to music for 20 minutes, interventions name: Not listening to music, outcomesModule primaryOutcomes measure: Pain tolerance, secondaryOutcomes measure: Heart rate variability (HRV), secondaryOutcomes measure: Level of perceived anxiety, Spielberger State-Trait Anxiety Inventory (STAI)-6 questionnaire, secondaryOutcomes measure: Valence and arousal, Self-Assessment manikin (SAM) questionnaire, secondaryOutcomes measure: Music listening Questionnaire, secondaryOutcomes measure: Pain intensity, secondaryOutcomes measure: Pain unpleasantness, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 64 Years, stdAges: ADULT, contactsLocationsModule locations facility: Erasmus Medical Center, city: Rotterdam, zip: 3015 GD, country: Netherlands, contacts name: Emy S van der Valk Bouman, MD, role: CONTACT, phone: +31646461901, email: e.vandervalkbouman@erasmusmc.nl, contacts name: Antonia S Becker, MD, role: CONTACT, phone: +31641188966, email: a.becker@erasmusmc.nl, contacts name: Markus Klimek, MD PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 51.9225, lon: 4.47917, hasResults: False
protocolSection identificationModule nctId: NCT06286124, orgStudyIdInfo id: 8612, briefTitle: Midline Restoration After HYbriD Hernia RepAir Surgery (HYDRA), acronym: HYDRA, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2027-04, completionDateStruct date: 2028-04, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Erasmus Medical Center, class: OTHER, collaborators name: Medtronic, collaborators name: Alrijne Hospital, descriptionModule briefSummary: The goal of this observational study is to learn about the functioning of the abdominal wall in patients who underwent hybrid (open- and laparoscopic) incisional hernia repair. The main objective is to assess the anatomical restoration and function of the linea alba one year after surgery by ultrasonography and mean peak torque during trunk flexion using a BioDex machine., conditionsModule conditions: Incisional Hernia of Midline of Abdomen, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 52, type: ESTIMATED, armsInterventionsModule interventions name: Hybrid Surgery, outcomesModule primaryOutcomes measure: Mean peak torque 1 year, secondaryOutcomes measure: Mean peak torque 2 years, secondaryOutcomes measure: Recurrent Incisional Hernia, secondaryOutcomes measure: Severity of surgical complications, secondaryOutcomes measure: Surgical complications, secondaryOutcomes measure: General Quality of Life, secondaryOutcomes measure: Mesh specific Quality of Life, secondaryOutcomes measure: Scar satisfaction, secondaryOutcomes measure: Pain in the abdominal region, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Alrijne Hospital, city: Leiden, country: Netherlands, contacts name: Willem Hueting, MSc, role: CONTACT, geoPoint lat: 52.15833, lon: 4.49306, hasResults: False
protocolSection identificationModule nctId: NCT06286111, orgStudyIdInfo id: ASU MD, briefTitle: Red Cell Distribution Width as a Predictor for Post Operative Atrial Fibrillation After Open Heart Surgries, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-25, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-08-01, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-04-23, sponsorCollaboratorsModule leadSponsor name: Ain Shams University, class: OTHER, descriptionModule briefSummary: In this study we investigate the correlation between RDW and POAF, as we use the RDW as a predictor for inflammation for prediction of POAF, conditionsModule conditions: Atrial Fibrillation, conditions: Inflammatory Marker, conditions: Heart; Surgery, Heart, Functional Disturbance as Result, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 76, type: ESTIMATED, outcomesModule primaryOutcomes measure: Red cell distribution width as a predictor for Post-operative Atrial fibrillation after Open Heart Surgeries, eligibilityModule sex: ALL, minimumAge: 35 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06286098, orgStudyIdInfo id: ALA in Pediatrics on HD, briefTitle: Alpha Lipoic Acid in Pediatrics on Hemodialysis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-20, primaryCompletionDateStruct date: 2024-09-20, completionDateStruct date: 2024-10-20, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Ain Shams University, class: OTHER, collaborators name: Eva Pharma, descriptionModule briefSummary: The goal of this clinical trial is to test alpha lipoic acid in children undergoing hemodialysis. The main questions it aims to answer are:* Will the use of alpha lipoic acid lower cardiovascular events in that population?* Is the incidence of those cardiovascular events linked to the oxidative stress and endothelial dysfunction in that population?* Will the drug cause side effects?Participants will:* take either one dose daily of 600mg tablet Alpha lipoic acid orally or a look-alike tablet containing no drug.* be monitored for the occurrence of cardiovascular events (stroke, angina, etc.)* be monitored for the occurrence of side effects* give blood samples for testing serum levels of E-selectin biomarker and superoxide dismutase enzyme* undergo clinical examinations (Echocardiogram, Duplex ultrasonography, Intima-Media-Thickness) Researchers will compare between the group taking alpha lipoic acid and the group taking the look-alike tablet., conditionsModule conditions: Hemodialysis Complication, conditions: Pediatric Kidney Disease, conditions: Cardiovascular Complication, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Alpha lipoic acid, interventions name: Placebo, outcomesModule primaryOutcomes measure: Serum level of E-Selectin, secondaryOutcomes measure: Serum levels of superoxide dismutase (SOD), secondaryOutcomes measure: Number of cardiovascular events, secondaryOutcomes measure: Number of Adverse effects, eligibilityModule sex: ALL, minimumAge: 8 Years, maximumAge: 16 Years, stdAges: CHILD, contactsLocationsModule locations facility: New Pediatrics Hospital, Faculty of Medicine, Ain Shams University, city: Cairo, state: El Weili, zip: 11381, country: Egypt, contacts name: Mahmoud Mohsen, Pharmacist, role: CONTACT, phone: +201275811494, email: mahmoudfast41@gmail.com, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06286085, orgStudyIdInfo id: 337788, briefTitle: A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma, acronym: MODELS, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-27, primaryCompletionDateStruct date: 2024-04-24, completionDateStruct date: 2024-07-24, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-04-04, sponsorCollaboratorsModule leadSponsor name: Portsmouth Hospitals NHS Trust, class: OTHER_GOV, descriptionModule briefSummary: This study aims to assess the concordance of international asthma guidelines in the diagnosis of asthma and explore the presence of airways disease using additional non-guideline physiologic criteria, such as IOS (impulse osciollometry), not included in the guidelines, but available in the Portsmouth lung function service., conditionsModule conditions: Asthma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 750, type: ESTIMATED, armsInterventionsModule interventions name: Lung function tests, outcomesModule primaryOutcomes measure: International asthma guidelines scores, primaryOutcomes measure: non-guideline physiologic criteria, secondaryOutcomes measure: non-guideline physiologic criteria for asthma., secondaryOutcomes measure: Comparison of the diagnostic outcomes of each guideline with a "reference standard"., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Portsmouth Hospitals University NHS Trust, status: RECRUITING, city: Portsmouth, country: United Kingdom, contacts name: Laura Marshall, role: CONTACT, phone: 02392286000, email: research.office@porthosp.nhs.uk, geoPoint lat: 50.79899, lon: -1.09125, hasResults: False
protocolSection identificationModule nctId: NCT06286072, orgStudyIdInfo id: YCEYHANS, briefTitle: The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-01, primaryCompletionDateStruct date: 2024-01-30, completionDateStruct date: 2024-03-30, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Kirsehir Ahi Evran Universitesi, class: OTHER, descriptionModule briefSummary: COPD is an important respiratory system disease that progresses with damage to the airways.Increased mucus secretion and thickening in the airways causes obstruction.This obstruction causes symptoms such as shortness of breath, cough, phlegm and wheezing.The most obvious problem that the emerging symptoms will cause for the patient is fatigue.Coping with fatigue is an important problem in COPD.The main questions it aims to answer are:1. Does the training given in COPD affect the level of fatigue?2. Do the education given and text messages sent regarding COPD affect the level of fatigue?In this study, patients were given informative education about COPD and ways to cope with fatigue were explained. Then, in order to increase the permanence of the training, motivational messages and short briefings were continued for 8 weeks.2 messages were sent per week. Three groups were created to reveal the effectiveness of the trainings and messages.Group 1 was trained and messages were sent for 8 weeks. Group 2 was trained and no message was sent. Group 3 is the control group. No training has been provided other than routine maintenance.The initial information of all groups was taken again at the end of the 8th week.Main outcomes:* Dyspnea severity,* COPD general conditions and* Fatigue level. The results obtained will be interpreted by comparing between 3 groups., conditionsModule conditions: Copd, conditions: Fatigue, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomised Controlled Trial, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Education and message, outcomesModule primaryOutcomes measure: Fatigue Level, primaryOutcomes measure: Dyspnea Severity, secondaryOutcomes measure: COPD general condition, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 85 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Yasemin CEYHAN, status: RECRUITING, city: Kırşehir, state: Center, zip: 40100, country: Turkey, contacts name: Yasemin CEYHAN, PhD, role: CONTACT, phone: +9054645898065, email: yasemin-ceyhan@hotmail.com, contacts role: CONTACT, phoneExt: CEYHAN, email: yasemin-ceyhan@hotmail.com, contacts name: Yasemin CEYHAN, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.14583, lon: 34.16389, hasResults: False
protocolSection identificationModule nctId: NCT06286059, orgStudyIdInfo id: Phentolamine for CA-AKI, briefTitle: Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-07, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-01-31, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Helwan University, class: OTHER, descriptionModule briefSummary: To evaluate the efficacy and safety of phentolamine in prevention of CA-AKI following complex PCI in patients at high risk of CA-AKI., conditionsModule conditions: CA-AKI - Contrast-Associated Acute Kidney Injury, conditions: Coronary Artery Disease, conditions: Acute Coronary Syndrome, conditions: Adrenergic Receptor Antagonist Adverse Reaction, designModule studyType: INTERVENTIONAL, phases: PHASE2, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomised controlled clinical trial, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: Single Blinded, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Phentolamine, outcomesModule primaryOutcomes measure: Rate of CA-AKI, secondaryOutcomes measure: Peak of serum creatinine elevation, secondaryOutcomes measure: Duration of CA-AKI, secondaryOutcomes measure: Change in HR, secondaryOutcomes measure: Change in SBP, secondaryOutcomes measure: Change in DBP, secondaryOutcomes measure: Urine output, secondaryOutcomes measure: Rate of RRT, secondaryOutcomes measure: Rate of MACE, secondaryOutcomes measure: Rate of rehospitalization, secondaryOutcomes measure: Duration of hospitalization, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Badr university hospital, status: RECRUITING, city: Badr, state: Cairo, country: Egypt, contacts name: Mohammed Soliman, MBBCH, role: CONTACT, phone: +201032137563, email: Mohammed_Mostafa@med.helwan.edu.eg, hasResults: False